Brad Calvin

Brad Calvin is a highly experienced professional who has held various key roles in the healthcare industry. Brad co-founded AsedaSciences and currently serves as the President and Co-Founder of the company. Throughout their career, Brad has been instrumental in defining strategic visions, leading marketing functions, and managing business units across multiple companies such as MaxCyte, Inc., GenMark Diagnostics, Beckman Coulter, and Abbott Diagnostics. With a background in B.Sc. Immunology, Microbiology, and Biochemistry from Curtin University, Brad has a strong foundation in the field.